Jpmorgan Chase & CO Ocugen, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Ocugen, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 141,658 shares of OCGN stock, worth $242,235. This represents 0.0% of its overall portfolio holdings.

Number of Shares
141,658
Previous 296,615 52.24%
Holding current value
$242,235
Previous $237,000 57.81%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$0.52 - $0.9 $80,577 - $139,461
-154,957 Reduced 52.24%
141,658 $100,000
Q4 2024

Feb 12, 2025
BUY
$0.72 - $1.08 $127,867 - $191,801
177,594 Added 149.21%
296,615 $237,000
Q3 2024

Dec 26, 2024
BUY
$0.98 - $1.95 $9,577 - $19,057
9,773 Added 8.95%
119,021 $117,000
Q3 2024

Nov 08, 2024
BUY
$0.98 - $1.95 $9,577 - $19,057
9,773 Added 8.95%
119,021 $117,000
Q2 2024

Dec 26, 2024
SELL
$1.18 - $1.98 $11,532 - $19,350
-9,773 Reduced 8.21%
109,248 $169,000
Q2 2024

Aug 12, 2024
SELL
$1.18 - $1.98 $333,558 - $559,700
-282,677 Reduced 72.13%
109,248 $169,000
Q1 2024

Dec 26, 2024
BUY
$0.5 - $1.83 $136,452 - $499,414
272,904 Added 229.29%
391,925 $642,000
Q1 2024

May 10, 2024
BUY
$0.5 - $1.83 $104,556 - $382,674
209,112 Added 114.39%
391,925 $642,000
Q4 2023

Dec 26, 2024
BUY
$0.36 - $0.57 $22,965 - $36,361
63,792 Added 53.6%
182,813 $104,000
Q4 2023

Feb 12, 2024
BUY
$0.36 - $0.57 $17,400 - $27,551
48,336 Added 35.94%
182,813 $104,000
Q3 2023

Nov 14, 2023
SELL
$0.4 - $0.62 $1.16 Million - $1.8 Million
-2,905,579 Reduced 95.58%
134,477 $53,000
Q2 2023

Aug 11, 2023
SELL
$0.45 - $0.88 $45,675 - $89,320
-101,501 Reduced 3.23%
3,040,056 $1.64 Million
Q1 2023

May 18, 2023
BUY
$0.82 - $1.33 $136,466 - $221,341
166,422 Added 5.59%
3,141,557 $2.67 Million
Q1 2023

May 11, 2023
SELL
$0.82 - $1.33 $649,221 - $1.05 Million
-791,733 Reduced 21.02%
2,975,135 $2.53 Million
Q4 2022

Feb 13, 2023
BUY
$1.11 - $1.87 $704,497 - $1.19 Million
634,682 Added 20.26%
3,766,868 $4.9 Million
Q3 2022

Nov 14, 2022
SELL
$1.75 - $3.1 $283,643 - $502,454
-162,082 Reduced 4.92%
3,132,186 $5.58 Million
Q2 2022

Aug 11, 2022
SELL
$1.83 - $3.45 $1.32 Million - $2.49 Million
-721,474 Reduced 17.97%
3,294,268 $7.48 Million
Q1 2022

May 11, 2022
BUY
$2.34 - $4.72 $1.62 Million - $3.27 Million
693,786 Added 20.88%
4,015,742 $13.3 Million
Q4 2021

Feb 10, 2022
BUY
$4.38 - $15.67 $12.1 Million - $43.3 Million
2,762,832 Added 494.14%
3,321,956 $15.1 Million
Q3 2021

Nov 12, 2021
BUY
$6.36 - $8.51 $3.56 Million - $4.76 Million
559,124 New
559,124 $4.01 Million

Others Institutions Holding OCGN

# of Institutions
112
Shares Held
64.6M
Call Options Held
604K
Put Options Held
253K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $370M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email